Document is current
Any future updates will be listed below
-
Authors
Chen, Kenneth
O’Brien, Jonathan https://orcid.org/0000-0002-9614-6690
McVey, Aoife
Jenjitranant, Pocharapong
Kelly, Brian D.
Kasivisvanathan, Veeru
Lawrentschuk, Nathan
Murphy, Declan G. https://orcid.org/0000-0002-7500-5899
Azad, Arun A.
- License Information
-
More Information
Article History
Accepted: 10 October 2022
First Online: 12 December 2022
Competing interests
: D.G.M. has received reimbursement for participation in advisory boards and delivering lectures from Astellas Pharmaceuticals, Janssen Pharma, Bayer, Ipsen, Ferring and AstraZeneca. K.C. has received honoraria for participation in advisory boards and delivering lectures from Astellas, Janssen Pharma, Bayer, AstraZeneca. V.K. receives funding from Prostate Cancer UK and the John Black Charitable Foundation for unrelated work. A.A.A. has been a consultant for Astellas, Janssen, Novartis, Aculeus Therapeutics; a speaker for Astellas, Janssen, Novartis, Amgen, Ipsen, Bristol Myers Squibb, Merck Serono and Bayer; received honoraria from Astellas, Novartis, Sanofi, AstraZeneca, Tolmar, Telix, Merck Serono, Janssen, Bristol Myers Squibb, Ipsen, Bayer, Pfizer, Amgen, Noxopharm, Merck Sharpe Dome, Aculeus Therapeutics; is on the scientific advisory board of Astellas, Novartis, Sanofi, AstraZeneca, Tolmar, Pfizer, Telix, Merck Serono, Janssen, Bristol Myers Squibb, Ipsen, Bayer, Merck Sharpe Dome, Amgen, Noxopharm; received research funding from Astellas (investigator), Merck Serono (investigator), AstraZeneca (investigator), Bristol Myers Squibb (institutional), AstraZeneca (institutional), Aptevo Therapeutics (institutional), Glaxo Smith Kline (institutional), Pfizer (institutional), MedImmune (institutional), Astellas (institutional), SYNthorx (institutional), Bionomics (institutional), Sanofi Aventis (institutional), Novartis (institutional), Ipsen (institutional), Exelixis (institutional), Merck Sharpe Dome (institutional), Janssen (institutional), Eli Lilly (institutional) and Gilead Sciences (institutional). The other authors declare no competing interests.
